3-38551133-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PM1PM2PP2
The NM_000335.5(SCN5A):c.5236G>A(p.Val1746Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000248 in 1,613,900 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000335.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SCN5A | NM_001099404.2 | c.5239G>A | p.Val1747Met | missense_variant | Exon 28 of 28 | ENST00000413689.6 | NP_001092874.1 | |
SCN5A | NM_000335.5 | c.5236G>A | p.Val1746Met | missense_variant | Exon 28 of 28 | ENST00000423572.7 | NP_000326.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SCN5A | ENST00000413689.6 | c.5239G>A | p.Val1747Met | missense_variant | Exon 28 of 28 | 5 | NM_001099404.2 | ENSP00000410257.1 | ||
SCN5A | ENST00000423572.7 | c.5236G>A | p.Val1746Met | missense_variant | Exon 28 of 28 | 1 | NM_000335.5 | ENSP00000398266.2 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 152010Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000239 AC: 6AN: 251280Hom.: 0 AF XY: 0.0000294 AC XY: 4AN XY: 135876
GnomAD4 exome AF: 0.0000267 AC: 39AN: 1461890Hom.: 1 Cov.: 35 AF XY: 0.0000330 AC XY: 24AN XY: 727248
GnomAD4 genome AF: 0.00000658 AC: 1AN: 152010Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1AN XY: 74246
ClinVar
Submissions by phenotype
not provided Uncertain:2
The V1747M variant of uncertain significance in the SCN5A gene has been reported previously in a Japanese individual diagnosed with LQTS; however, no detailed clinical information or segregation data were provided (Itoh et al., 2010). The V1747M variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). Although missense variants in nearby residues (G1743E, A1746T, G1748D) have been reported in the Human Gene Mutation Database in association with SCN5A-related disorders (Stenson et al., 2014), the pathogenicity of these variants has not been definitively determined. The V1747M variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. Furthermore, this substitution occurs at a position where amino acids with similar properties to valine (V) are tolerated across species, and methionine (M) is tolerated at this position in at least vertebrates. Additionally, in silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. -
This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 1747 of the SCN5A protein (p.Val1747Met). This variant is present in population databases (rs199473630, gnomAD 0.006%). This missense change has been observed in individual(s) with long QT syndrome (PMID: 20541041, 37089884). ClinVar contains an entry for this variant (Variation ID: 67970). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Cardiac arrhythmia Uncertain:2
This missense variant replaces valine with methionine at codon 1747 of the SCN5A protein. Computational prediction is inconclusive regarding the impact of this variant on protein structure and function (internally defined REVEL score threshold 0.5 < inconclusive < 0.7, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in an individual with long QT syndrome (PMID: 20541041) and in an individual affected with Brugada syndrome and dilated cardiomyopathy (PMID: 28567303). This variant has been identified in 7/282612 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
This missense variant replaces valine with methionine at codon 1747 of the SCN5A protein. Computational prediction is inconclusive regarding the impact of this variant on protein structure and function (internally defined REVEL score threshold 0.5 < inconclusive < 0.7, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in an individual with long QT syndrome (PMID: 20541041) and in an individual affected with Brugada syndrome and dilated cardiomyopathy (PMID: 28567303). This variant has been identified in 7/282612 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
not specified Uncertain:1
This missense variant results in a substitution of valine with methionine at codon 1747 of the SCN5A gene (transcript NM_001099404.1). This variant has been reported in ClinVar (67970) NM_000335.5 (SCN5A):c.5236G>A (p.Val1746Met) and occurred in GnomAD with a total MAF of 0.0024% and highest MAF of 0.0058% in the East Asian population. This position is conserved. In silico functional algorithms conflict, predicting it as tolerated (SIFT) and possibly damaging (PolyPhen), but no functional studies were performed to confirm these predictions. The variant has been observed in an individual with long QT syndrome (PMID: 20541041). In conclusion, the available evidence is insufficient to determine the pathogenicity of this variant. Therefore, it is classified as a Variant of Uncertain Significance. -
Cardiovascular phenotype Uncertain:1
The c.5239G>A (p.V1747M) alteration is located in exon 28 (coding exon 27) of the SCN5A gene. This alteration results from a G to A substitution at nucleotide position 5239, causing the valine (V) at amino acid position 1747 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Congenital long QT syndrome Other:1
This variant has been reported as associated with Long QT syndrome in the following publications (PMID:20541041). This is a literature report, and does not necessarily reflect the clinical interpretation of the Imperial College / Royal Brompton Cardiovascular Genetics laboratory. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at